Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference13% 
- Check34 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3% 
- Check48 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, removing the old revision tag and deleting the small 'Back to Top' element.SummaryDifference0.8% 
- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8% 
- Check62 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference10% 
- Check77 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3% 
Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.